Securities research is a discipline within the financial services industry. Securities research professionals are known most generally as “analysts”, “research analysts”, or “securities analysts”; all the foregoing terms are synonymous. Research analysts produce research reports and typically issue a recommendation: buy (“overweight”), hold, or sell (“underweight”); see target price. These reports can be accessed from a number of sources, and brokerages will often offer the reports free to their customers. Research can be categorized by the security type, as well as by whether it is buy-side research or sell-side research; analysts further focus on particular industries. Although usually associated with fundamental analysis, research also focuses on technical analysis, and reports will often include both. See also Financial analyst #Securities firms.
Securities analysts are commonly divided between the two basic kinds of securities: equity analysts (researching stocks and their issuers) and fixed income analysts (researching bond issuers); there are various other financial instruments. There are some analysts who cover all of the securities of a particular issuer, stocks and bonds alike.
Securities analysts are usually further subdivided by industry specialization (or sectors) — among the industries with the most analyst coverage are biotechnology, financial services, energy, and computer hardware, software and services. Analysts will regularly attend quarterly earnings conference calls; see also earnings guidance.
Fixed income analysts are also often subdivided by asset class—among the fixed income asset classes with the most analyst coverage are convertible bonds, high yield bonds (see high-yield debt), and distressed bonds (see distressed securities). Although technically not securities, syndicated bank loans typically fall within the domain of fixed income analysts, and are covered, as if they were bonds, by reference to the industry of their borrowers or asset class in which their credit quality would place them.
Research can be further categorized as buy-side research or sell-side research. Sell-side research is conducted by sell-side analysts at investment banks and independent equity research boutiques, and is sold to buy-side investors. Buy-side research, however, is usually not published as it created for internal use at an asset manager or hedge fund. Sell-side research is offered as part of a broad set of financial services including broking and corporate finance.
New regulation in Europe, Markets in Financial Instruments Directive II (MiFID II), is set to change how research is bought. Research must be “unbundled” from execution costs and priced by the research provider. It has typically been accessed by institutional investors through Thomson Reuters subscription services or Bloomberg terminals but marketplaces like Research Exchange Ltd have emerged where individual research reports or subscriptions can be purchased.
Independent equity research has largely sprung into existence as a result of scandals such as Enron, Lernout & Hauspie and Worldcom where investment banks wrote positive research despite deteriorating fundamentals or fraudulent management. Credit rating agencies such as Moody’s, Fitch, and S&P provide a similar service for bond securities. There are also a few retail investor firms such as Morningstar, SEENSCO, Valueline, and Zacks Investment Research.
Entrance into the profession, which is generally very well paid and prestigious, is highly competitive. Those who enter the profession at the junior level, typically have an undergraduate degree from a leading college or university and one to a few years of experience in some other discipline of finance or (lacking such experience) an MBA or other relevant advanced degree. Those who enter the field in a junior capacity, can progress to a senior capacity in a fairly brief period of time (two to four years) if they prove themselves talented; often such advancement is greatly aided by earning a Chartered Financial Analyst charter (which requires passing of three examinations). Many securities analysts have directly entered the profession at a more senior level; such persons typically have an MBA or other relevant advanced degree and a number of years of progressively responsible experience either in another finance profession, or in the industry which they will be covering as an analyst.
Securities analysts are generally employed in one of three capacities: sell-side analysts (who work for a broker-dealer and indirectly for broker-dealer’s trading customers), buy-side analysts (who work for institutional investors, such as hedge funds, mutual funds, pension funds, proprietary trading operations of banks and brokers, endowments, and insurance companies), and independent analysts, who work for firms which sell research to sell-side and/or buy-side firms, but who do not themselves engage in securities transactions.
Buy-side analysts generally do their work in private; publishing research reports and issuing public opinions on a security is generally confined to sell-side and independent analysts. However, the amount of formally published sell-side research is generally thought to be declining, as it becomes more difficult for brokers to gain a clear revenue stream from the investment. The direct connection between securities research and the underwriting of new issues, which enabled research analysts to claim a share of investment banking fees, was severed as a result of government investigations into excesses of some sell-side analysts in the late 1990s; see, for example, Henry Blodget. In actuality, even before the government probes, direct contact was always an official violation of rules and ethics. Attorneys and compliance personnel, together known as Chinese wall personnel, were instructed to hinder all “wall crossings” to the best of their ability. However, in the late 1990s this proved to be extremely difficult as well-connected research analysts found ways to go “over the wall”.
In the US, as of 2002, investment professionals seeking to become sell-side equity research analysts must pass the Research Analyst examination administered by FINRA. The exam is divided into two parts: the 86 and 87. The Series 86 Research Analyst exam is the Quantitative portion consisting of material from introductory economics, and financial accounting. The Series 87 Research Analyst exam is the Regulatory portion consisting of material from the Securities Act of 1933, Securities Exchange Act of 1934, NASD and NYSE Rules. The Series 7 examination/license is a pre-requisite for the Research Analyst exams. Successful completion of the CFA level I & II exams provides a waiver for the Series 86 exam, but not the Series 87 examination.
In Hong Kong, investment professionals must pass the Paper 1 administered by the Hong Kong Securities Institute. Passing this exam allows the individual to receive the Type 4 license to be a publishing research analyst in Hong Kong.
Buy-side and independent research are generally unregulated. Sell-side research is subject to regulation by the securities authorities of the locales where it is performed. The large majority of all sell-side research is performed either in the United Kingdom or the United States. UK sell-side research is regulated by the Financial Services Authority. US sell-side research has a more complex regime of regulation. The U.S. Securities and Exchange Commission has prescribed certain relevant rules (among them Regulation AC and Regulation FD) but has generally delegated research regulation to the self-regulatory organizations. The principal SROs (the National Association of Securities Dealers and the New York Stock Exchange) have issued detailed regulations of equity research, and much more cursory regulation of fixed income research. (With respect to the latter, the NYSE and the NASD have re-delegated the substance of regulation to the broker-dealer trade group Securities Industry and Financial Markets Association as the merger successor of the Bond Market Association, to whom the role was originally assigned.) The impact upon securities research regulation of the pending merger of the NASD with the regulatory arm of the NYSE is currently uncertain.
In the immediate aftermath of the excesses of the 1990s referred to above, Eliot Spitzer, Governor of the State of New York, asserted a significant role in policing securities research performed by New York-based analysts; it is unclear whether oversight by the New York State Attorney General will become a long-term meaningful component of securities research. The going-forward conduct provisions of a master settlement agreement between (on the one hand) most of the aforesaid U.S. regulators and (on the other hand) many of the largest U.S. broker-dealers, is an important source of ongoing regulation, with the force of law for the broker-dealers who are party to it, and a strong, if not formally legally binding effect, on broker-dealers not party to it.
The latest rule changes are coming into effect in Europe under MiFID II. Research has been deemed an inducement to trade and must be “unbundled” from execution costs. The new rules around Research Unbundling are viewed as a major challenge by asset managers as they materially alter the way in which research has been consumed. Research budgets must be set in advance, payments for research separated from execution, the quality of research regularly assessed, and auditable records of consumption and payments kept. New platforms such as RSRCHXchange, Electronic Research Interchange, and Smartkarma launched in anticipation of the rules coming into effect. At the same time, accelerator-type initiatives like Boost Research are being created to help independent analysts set up their own businesses for providing independent research and analysis.
- ^Zimmerman A. (nd). Analyst Reports. Zimmerman’s Research Guide.
- ^“ESMA Unveils New Rules for Research”. www.institutionalinvestor.com. Retrieved 2016-02-21.
- ^“Archived copy”. Archived from the original on 2010-05-06. Retrieved 2010-04-09.
- ^“Archived copy”. Archived from the original on 2010-01-10. Retrieved 2010-03-09.
- ^“Archived copy”. Archived from the original on 2010-08-06. Retrieved 2010-03-09.
- ^ Jump up to:ab “MiFID (II) and MiFIR”. www.esma.europa.eu. Retrieved 2016-02-21.
- ^“MiFID II priority for fund managers, according to Deloitte study -thetradenews.com”. www.thetradenews.com. Retrieved 2016-02-21.
- ^“Accelerating Tomorrow’s Independent Research Providers”. 2018-07-29. Retrieved 2018-08-07.
Ofer Abarbanel is a 25 year securities lending broker and expert who has advised many Israeli regulators, among them the Israel Tax Authority, with respect to stock loans, repurchase agreements and credit derivatives. Founder TBIL.co STATX Fund.